Marcus Conrad Selected Research

Marcus Conrad Research Topics

Disease

32	Neoplasms (Cancer) 04/2024 - 08/2009
7	Reperfusion Injury 03/2024 - 12/2011
4	Ischemia 11/2021 - 12/2011
3	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2021
3	Neuroblastoma 01/2024 - 01/2018
3	Hypoxia (Hypoxemia) 10/2023 - 12/2011
3	Atrophy 11/2021 - 05/2014
3	Necrosis 01/2021 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2020
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 03/2008
3	Inflammation (Inflammations) 10/2019 - 08/2011
2	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 01/2020
2	Disease Progression 04/2022 - 10/2017
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 12/2014
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 06/2014
2	Starvation 10/2021 - 01/2018
2	Melanoma (Melanoma, Malignant) 12/2020 - 11/2016
2	Carcinogenesis 01/2018 - 11/2010
2	Seizures (Absence Seizure) 01/2018 - 03/2010
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2011 - 05/2011
1	Acute Liver Failure (Fulminant Hepatic Failure) 03/2024
1	Rupture 10/2023
1	Cysts 07/2023
1	Glomerulonephritis 01/2023
1	Lupus Nephritis 01/2023
1	Cognitive Dysfunction 04/2022
1	Hypersensitivity (Allergy) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Sedaghatian type Spondylometaphyseal dysplasia 01/2022
1	Poisoning 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 11/2021
1	Strudwick syndrome 11/2021
1	Perinatal Death 11/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Colitis 01/2021

Drug/Important Bio-Agent (IBA)

15	IronIBA 04/2024 - 03/2017
10	Glutathione (Reduced Glutathione)IBA 07/2023 - 11/2010
10	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 07/2023 - 09/2009
6	EnzymesIBA 01/2023 - 11/2010
5	LipidsIBA 01/2024 - 12/2014
4	Selenoproteins (Selenoprotein)IBA 11/2021 - 03/2010
4	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 11/2010
4	Cystine (L-Cystine)IBA 01/2021 - 04/2011
4	Glutamic Acid (Glutamate)FDA Link 01/2021 - 04/2011
4	ThioredoxinsIBA 04/2015 - 03/2008
4	Thioredoxin-Disulfide ReductaseIBA 04/2015 - 03/2008
3	SeleniumIBA 11/2021 - 03/2010
3	Cysteine (L-Cysteine)FDA Link 10/2021 - 06/2014
3	AntiportersIBA 01/2021 - 06/2014
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2011
3	AntioxidantsIBA 10/2017 - 11/2010
3	Vitamin E FDA LinkGeneric 07/2015 - 08/2013
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 10/2023 - 04/2015
2	Vitamin K FDA Link 07/2023 - 01/2022
2	NAD (NADH)IBA 07/2023 - 01/2020
2	SelenocysteineIBA 01/2023 - 01/2018
2	selenium transferaseIBA 11/2021 - 05/2014
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2021 - 11/2019
2	erastinIBA 01/2021 - 01/2018
2	Peptides (Polypeptides)IBA 01/2020 - 11/2016
2	Phospholipids (Phosphatides)FDA LinkGeneric 11/2019 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2018
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 01/2017 - 03/2010
1	Interleukin-2 (IL2)IBA 04/2024
1	trans- 1,4- Bis(2- chlorobenzaminomethyl)cyclohexane DihydrochlorideIBA 03/2024
1	Acetaminophen (Paracetamol)FDA LinkGeneric 03/2024
1	7-dehydrocholesterolIBA 01/2024
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2023
1	Iron-Regulatory Proteins (Iron-Responsive Element Binding Proteins)IBA 10/2023
1	ElementsIBA 10/2023
1	UbiquinoneIBA 07/2023
1	Selenoprotein PIBA 01/2023
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 01/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2023
1	Apolipoproteins E (ApoE)IBA 04/2022
1	ApolipoproteinsIBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	human PRMT2 proteinIBA 01/2022
1	CalciumIBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022
1	liproxstatin-1IBA 01/2022
1	selenocysteinyl-tRNAIBA 11/2021
1	MTOR InhibitorsIBA 10/2021
1	torinIBA 10/2021
1	BODIPY581IBA 10/2021
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 10/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021
1	tung oilIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Verteporfin (Visudyne)FDA Link 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021

Therapy/Procedure

12	Therapeutics 07/2023 - 11/2016
1	Immunotherapy 04/2024
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2024
1	Oral Administration 01/2021